PREVENTCD is performed by 17 European partners from the industry, academic or patient organisation. Who is involved exactly?

The family study is performed by 10 medical centres in the Netherlands, Italy, Spain, Hungary, Croatia, Poland, and Israel and the patient organisation AOECS.

The population study is performed by the Umea University in Sweden.

The industries involved in this project are Numico, Phadia and Eurospital.

The genetics department of the University Medical Centre Groningen,

The immunology departments of Leiden University Medical Centre and the University of Oslo will be involved in this project.